GPC3 and hepatocellular carcinoma: The addition of CYT-303, an NKCE that binds both NK cells and GPC3, significantly augmented the cytotoxic effects of peripheral blood-derived NK cells on Hep3B spheroids in a dose-dependent manner, offering a promising avenue for immunotherapy in HCC.